FaZe Holdings Short Squeeze Coming? DeSPAC Tops Leaderboard — 5 Short Squeeze Stocks That May Soar This Week
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move.
Dow Falls Over 200 Points After Friday’s Plunge
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Monday.
SelectQuote Shares Plunge On Q4 Miss, Dismal Outlook
SelectQuote, Inc (NYSE:SLQT) reported a fourth-quarter FY22 revenue decline of 24.8% year-on-year to $139.4 million, missing the consensus of $199.2 million.…
HYTN Launches Nano Gummies Offering ‘Faster And More Consistent Cannabis Experience’
HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new Nano Gummies product.
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) Q2 2022 total revenue was CA$4.5 million ($3.45 million), up 60% year-over-year, driven by growth in the medical cannabis segment in Colombia and the United Kingdom.
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Jushi’s NuLeaf Acquisition Pays-Off, Strong Q2 Revenue Growth, Provides Outlook
Jushi Holdings Inc. (OTCQX: JUSHF) (CSE:JUSH) released its financial results for the second quarter 2022 ended June 30, 2022, revealing total revenue of $72.8 million, an increase of 52.4% year-over-year and 17.6% as compared to Q1 2022.
Benzinga Before The Bell: Meta Loses Key Metaverse Official, US Government To Cancel Free At-Home COVID Tests, Singapore Mulls Rules To Regulate Cryptocurrency Trading And Other Top Financial Stories Monday, August 29
CNBC
No More Free COVID-19 At-Home Tests, Federal Government Says
Goldman Sachs Boosts Price Target On JinkoSolar Following Q2 Earnings, Also Check Out Other Major PT Changes Here
Oppenheimer raised the price target on S&P Global Inc. (NYSE: SPGI) from $404 to $419. Oppenheimer analyst Owen Lau maintained an Outperform rating on the stock. S&P Global shares fell 1% to $360.46 in pre-market trading.
Farmmi Gets Repeat Shipping Order To Southwest Asia
LISHUI, China, Aug. 29, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agricultural products supplier in China, received another repeatLISHUI, China, Aug. 29, 2022 /PRNewswire/ -- Farmmi, Inc.